Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Imiquimod Treatment of CIN Lesions (TOPIC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02329171
Recruitment Status : Terminated (Insufficient number of participants.)
First Posted : December 31, 2014
Last Update Posted : August 15, 2018
Sponsor:
Collaborator:
MEDA Pharma GmbH & Co. KG
Information provided by (Responsible Party):
Maastricht University Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : June 2016
Actual Study Completion Date : June 2016
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):